Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment

Table 1 Sample characteristics (n = 87)

Age at blood draw	66.4 \(\pm\) 9.6
Sex (% female, % male)	48%, 52%
Years of education	17.0 \(\pm\) 2.5
Ethnicity (% Hispanic or Latino)	7%
Race (% White, % Black, % Asian)	95%, 1%, 4%
APOE-ε4 alleles (% 1 ε4, % 2 ε4)	45%, 16%
Clinical Stage (%MCI, % dementia)	61%, 39%
MMSE, /30	21.6 \(\pm\) 6.2
CDR-SoB, /18	4.2 \(\pm\) 2.6
Global Amyloid PET (Centiloids)	94.1 \(\pm\) 34.6

Data is presented as mean ± standard deviation for continuous variables, and % total available sample for categorical variables; n = 87 for all variables, except for MMSE (n = 85), and years of education (n = 83). CDR-SoB Clinical Dementia Rating – Sum of Boxes, MMSE Mini-Mental State Exam

ISSN: 1758-9193